Arrowstreet Capital’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $412K | Buy |
+21,983
| New | +$412K | ﹤0.01% | 1783 |
|
|
2021
Q4 | – | Sell |
-13,739
| Closed | -$499K | – | 1674 |
|
|
2021
Q3 | $499K | Buy |
+13,739
| New | +$499K | ﹤0.01% | 1418 |
|
|
2021
Q1 | – | Sell |
-126,056
| Closed | -$4.41M | – | 2482 |
|
|
2020
Q4 | $4.41M | Sell |
126,056
-42,026
| -25% | -$1.47M | 0.01% | 1245 |
|
|
2020
Q3 | $4.03M | Buy |
168,082
+57,557
| +52% | +$1.38M | 0.01% | 1246 |
|
|
2020
Q2 | $2.02M | Buy |
+110,525
| New | +$2.02M | ﹤0.01% | 1475 |
|